Ming-Rong Zhang

Synthesis of two novel [F]fluorobenzene-containing radiotracers via spirocyclic iodonium ylides and positron emission tomography imaging of translocator protein (18 kDa) in ischemic brain.

Unexpected decrease in in vivo binding of [H]QNB in the mouse cerebral cortex in the developing brain - A comparison with [C]NMPB.

Synthesis and evaluation of 4-(2-fluoro-4-[C]methoxyphenyl)-5-((2-methylpyridin-4-yl)methoxy)picolinamide for PET imaging of the metabotropic glutamate receptor 2 in the rat brain.

Developing native peptide-based radiotracers for PD-L1 PET imaging and improving imaging contrast by pegylation.

Correction: Developing native peptide-based radiotracers for PD-L1 PET imaging and improving imaging contrast by pegylation.

Radiosynthesis and evaluation of a novel monoacylglycerol lipase radiotracer: 1,1,1,3,3,3-hexafluoropropan-2-yl-3-(1-benzyl-1H-pyrazol-3-yl)azetidine-1-[C]carboxylate.

PET imaging on neurofunctional changes after optogenetic stimulation in a rat model of panic disorder.

I-IITM and At-AITM: Two Novel Small-Molecule Radiopharmaceuticals Targeting Oncoprotein Metabotropic Glutamate Receptor 1.

Synthesis and evaluation of 6-(C-methyl(4-(pyridin-2-yl)thiazol-2-yl)amino)benzo[d]thiazol-2(3H)-one for imaging γ-8 dependent transmembrane AMPA receptor regulatory protein by PET.

Radiosynthesis of [thiocarbonyl-C]disulfiram and its first PET study in mice.

Marriage of black phosphorus and Cu as effective photothermal agents for PET-guided combination cancer therapy.

[C]phosgene: Synthesis and application for development of PET radiotracers.

Synthesis and preliminary evaluation of 4-hydroxy-6-(3-[C]methoxyphenethyl)pyridazin-3(2H)-one, a C-labeled d-amino acid oxidase (DAAO) inhibitor for PET imaging.

Synthesis and preliminary evaluation of novel C-labeled GluN2B-selective NMDA receptor negative allosteric modulators.

3-(Cyclopropylmethyl)-7-((4-(4-[C]methoxyphenyl)piperidin-1-yl)methyl)-8-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine: Synthesis and preliminary evaluation for PET imaging of metabotropic glutamate receptor subtype 2.

Radiosynthesis and evaluation of 4-(6-[F]Fluoro-4-(5-isopropoxy-1-indazol-3-yl)pyridin-2-yl)morpholine as a novel radiotracer candidate targeting leucine-rich repeat kinase 2.

Off-tumor IDO1 target engagements determine the cancer-immune set point and predict the immunotherapeutic efficacy.

Harnessing the PD-L1 interface peptide for positron emission tomography imaging of the PD-1 immune checkpoint.

Quantification of monoacylglycerol lipase and its occupancy by an exogenous ligand in rhesus monkey brains using [F]T-401 and PET.

Upregulation of Striatal Metabotropic Glutamate Receptor Subtype 1 (mGluR1) in Rats with Excessive Glutamate Release Induced by N-Acetylcysteine.

Brain 5-HT receptor binding and its neural network related to behavioral inhibition system.

First-in-human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with F-T-401.

Development of a Stable Peptide-Based PET Tracer for Detecting CD133-Expressing Cancer Cells.

Characterization and Stabilization of a New Cu-Labeled Anti-EGFR Antibody NCAB001 for the Early Detection of Pancreatic Cancer with Positron Emission Tomography.

Automated radiosynthesis of [ C]MTP38-a phosphodiesterase 7 imaging tracer-using [ C]hydrogen cyanide for clinical applications.

Identification and quantitative structure-activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [Cu]Cu-ATSM.

Synthesis of [C]carbonyl-labeled cyclohexyl (5-(2-acetamidobenzo[d]thiazol-6-yl)-2-methylpyridin-3-yl)carbamate ([C-carbonyl]PK68) as a potential PET tracer for receptor-interacting protein 1 kinase.

Development of Novel Pt-Labeled Hoechst33258: Pt Is More Suitable than In for Targeting DNA.

Correction to: First‑in‑human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with F‑T‑401.

Rapid 'on-column' preparation of hydrogen [C]cyanide from [C]methyl iodide [C]formaldehyde.

A novel monoacylglycerol lipase-targeted F-labeled probe for positron emission tomography imaging of brown adipose tissue in the energy network.

PET-based classification of corticobasal syndrome.

Scandium Triflate-Catalyzed -[F]Fluoroalkylation of Aryl- Or Heteroaryl-Amines with [F]Epifluorohydrin under Mild Conditions.

In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study.

PEIGel: A biocompatible and injectable scaffold with innate immune adjuvanticity for synergized local immunotherapy.

Imaging of Transmembrane AMPA Receptor Regulatory Proteins by Positron Emission Tomography.

A quantitative in vivo imaging platform for tracking pathological tau depositions and resultant neuronal death in a mouse model.

C-Labeled Radiotracer for Noninvasive and Quantitative Assessment of the Thiocyanate Efflux System in the Brain.

High-Contrast Imaging of α-Synuclein Pathologies in Living Patients with Multiple System Atrophy.

A Machine Learning-Based Approach to Discrimination of Tauopathies Using [ F]PM-PBB3 PET Images.

Acetamidobenzoxazolone scaffold as a promising translocator protein (18 kDa, TSPO) marker for neuroinflammation imaging: Advancement in last decennial period.

Precise quantitative evaluation of pharmacokinetics of cisplatin using a radio-platinum tracer in tumor-bearing mice.

Assessment of cholesterol homeostasis in the living human brain.

Dynamic imaging analysis reveals Auger electron-emitting radio-cisplatin induces DNA damage depending on the cell cycle.

An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with F-PM-PBB3 (F-APN-1607).

Positron Emission Tomography Assessments of Phosphodiesterase 10A in Patients With Schizophrenia.

Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy.

Small-animal PET study for noninvasive quantification of transmembrane AMPA receptor regulatory protein -8 (TARP -8) in the brain.